Assets Endring Dato
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Almirall EUR 2.34B 192.16M 2023-06
Amarin USD 839.03M 20.99M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Artemis Alpha GBP 111.08M 18.39M 2022-06
AstraZeneca USD 96.09B 457M 2023-09
Bayer EUR 117.24B 4.43B 2023-09
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Demant DKK 29.83B 24M 2023-06
Exelixis USD 2.98B 165.56M 2023-09
Galapagos EUR 4.45B 71M 2023-09
Genmab DKK 35.24B 3.26B 2023-09
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
GN Store Nord DKK 31.04B 788M 2023-09
GRIFOLS EUR 21.44B 623.44M 2023-12
Hikma Pharmaceutical USD 4.62B 148M 2023-06
Insmed USD 1.33B 4.96M 2023-12
Lonza CHF 17.67B 316M 2023-06
Merck EUR 49.91B 1.12B 2023-09
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
UCB EUR 15.38B 486M 2023-06



Genmab Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.